Home › Graft-Versus-Host Disease › Illinois
Graft-Versus-Host Disease clinical trials in Illinois
3 studies for Graft-Versus-Host Disease are looking for participants at sites in Illinois.
Cities in Illinois
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- The University of Chicago Medical Center (UCMC), Chicago
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 16, 2026 · NCT04710576Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
- University of Chicago, Chicago
RecruitingPhase 2
Ages 2 and older · All sexes · Updated May 11, 2026 · NCT04380740A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- University of Illinois Medical Center - Hematology & Oncology, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.